These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33116389)

  • 1. iStent Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in a Japanese Glaucoma Population.
    Nitta K; Yamada Y; Morokado S; Sugiyama K
    Clin Ophthalmol; 2020; 14():3381-3391. PubMed ID: 33116389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Year Multicenter Outcomes of iStent
    Clement C; Howes F; Ioannidis AS; Shiu M; Manning D; Lusthaus J; Lim R; Skalicky SE; Goodwin T
    Clin Ophthalmol; 2020; 14():3507-3517. PubMed ID: 33149544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma.
    Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
    Ophthalmol Ther; 2018 Dec; 7(2):405-415. PubMed ID: 30430427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension.
    Clement C; Howes F; Ioannidis A; Shiu M; Manning D; Lusthaus JA; Skalicky SE; Goodwin TW
    Clin Ophthalmol; 2022; 16():2955-2968. PubMed ID: 36071724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.
    Hengerer FH; Auffarth GU; Riffel C; Conrad-Hengerer I
    Adv Ther; 2019 Jul; 36(7):1606-1617. PubMed ID: 31119690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study.
    Salimi A; Clement C; Shiu M; Harasymowycz P
    Ophthalmol Ther; 2020 Sep; 9(3):585-596. PubMed ID: 32613589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center.
    Guedes RAP; Gravina DM; Lake JC; Guedes VMP; Chaoubah A
    Adv Ther; 2019 Oct; 36(10):2797-2810. PubMed ID: 31440981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world Case Series of iStent or iStent inject Trabecular Micro-Bypass Stents Combined with Cataract Surgery.
    Manning D
    Ophthalmol Ther; 2019 Dec; 8(4):549-561. PubMed ID: 31422555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iStent Trabecular Micro-bypass Stent Implantation Combined with Phacoemulsification for Open-Angle Glaucoma: A 2-Year Post-marketing Surveillance Study in Japan.
    Inatani M; Kohama I; Chu A
    Adv Ther; 2022 Sep; 39(9):4076-4093. PubMed ID: 35790641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results.
    Salimi A; Watt H; Harasymowycz P
    Eye Vis (Lond); 2021 Nov; 8(1):43. PubMed ID: 34782017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-Year Effectiveness and Safety of Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in Patients with Glaucoma or Ocular Hypertension.
    Neuhann TH; Neuhann RT; Hornbeak DM
    Ophthalmol Ther; 2024 Aug; 13(8):2243-2254. PubMed ID: 38907091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of Two iStent
    Myers JS; Masood I; Hornbeak DM; Belda JI; Auffarth G; Jünemann A; Giamporcaro JE; Martinez-de-la-Casa JM; Ahmed IIK; Voskanyan L; Katz LJ
    Adv Ther; 2018 Mar; 35(3):395-407. PubMed ID: 29476443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma.
    Gallardo MJ; Supnet RA
    Clin Ophthalmol; 2019; 13():869-879. PubMed ID: 31239633
    [No Abstract]   [Full Text] [Related]  

  • 14. Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma.
    Saheb H; Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed IIK; Katz LJ
    Curr Eye Res; 2021 Feb; 46(2):224-231. PubMed ID: 32715828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities.
    Salimi A; Watt H; Harasymowycz P
    J Glaucoma; 2021 Mar; 30(3):266-275. PubMed ID: 33105306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification.
    Schweitzer JA; Hauser WH; Ibach M; Baartman B; Gollamudi SR; Crothers AW; Linn JE; Berdahl JP
    Ophthalmol Ther; 2020 Dec; 9(4):941-953. PubMed ID: 32789800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities.
    Salimi A; Lapointe J; Harasymowycz P
    Ophthalmol Ther; 2019 Dec; 8(4):563-575. PubMed ID: 31538316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study.
    Clement CI; Howes F; Ioannidis AS; Shiu M; Manning D
    Clin Ophthalmol; 2019; 13():491-499. PubMed ID: 30936680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Outcomes of Combined 2nd-Generation Trabecular Microbypass (iStent Inject) and Cataract Surgery for the Treatment of Primary Open-Angle Glaucoma in the Saudi Population.
    Al Habash A; Otaif W
    Ophthalmol Ther; 2021 Dec; 10(4):923-933. PubMed ID: 34351592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control.
    Hengerer FH; Auffarth GU; Conrad-Hengerer I
    Adv Ther; 2022 Mar; 39(3):1417-1431. PubMed ID: 35113323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.